Repression of activated aryl hydrocarbon receptor-induced transcriptional activation by 5a-dihydrotestosterone in human prostate cancer lncap and human breast cancer t47d cells

Journal of Pharmacological Sciences

Volumn 109, Issue 3, 2009, Pages 380-387

  Sanada, Noriko ^a   Gotoh, Yuka ^a   Shimazawa, Rumiko ^a   Klinge, Carolyn M ^b   Kizu, Ryoichi ^a  

^a DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

^b University of Louisville School of Medicine   (United States)

Author keywords

Androgen receptor; Aryl hydrocarbon receptor; Complex formation; Cross talk; Transcriptional activation

Indexed keywords

3 METHYLCHOLANTHRENE; 5ALPHA PREGNANE 3,20 DIONE; ANDROSTANOLONE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; LUCIFERASE; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANDROGENS; ARYL HYDROCARBON HYDROXYLASES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; DIHYDROTESTOSTERONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MALE; METHYLCHOLANTHRENE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 67249089061     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08328FP     Document Type: Article

References (36)

1. Hankinson O. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol. 1995;35:307-340.
2. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2000;97:779-782. (Pubitemid 30070386)
3. Safe SH. Modulation of gene expression and endocrine response pathways by 2,3,4,8-tetrachlorodibenzo-/>-dioxin and related compounds. Pharmacol Ther. 1995;67:247-281.
4. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity. Chemosphere. 1997;34:835-848.
5. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8- tetrachlorodibenza-/>-dioxm-induced toxicity. Toxicol Appl Pharmacol. 1996;140:173-179. (Pubitemid 26329475)
6. Mimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta. 2003;1619:263-268.
7. Peters JM, Narotsky MG, Elizondo G, Fernandez-Salguero PM, Gonzalez FJ, Abbott BD. Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol Sci. 1999;47:86-92. (Pubitemid 29214235)
8. Lin TM, Ko K, Moore RW, Simanainen U, Oberley TD, Peterson RE. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-/>-dioxin exposure on prostate and seminal vesicle development in C57BL /6 mice. Toxicol Sci. 2002;68:479-487.
9. Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J Cell Sci. 1998;111:3311-3322. (Pubitemid 28563034)
10. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, et al. Altered cell cycle control at the G2/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol. 2000;57:1056-1063. (Pubitemid 30253392)
11. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 1995;268:722-726.
12. Furness SG, Lees MJ, Whitelaw ML. The dioxin (aryl hydrocarbon) receptor as a model for adaptive responses of bHLH /PAS transcription factors. FEBS Lett. 2007;581:3616-3625. (Pubitemid 47086313)
13. Perdew GH. Chemical cross-linking of the cytosolic and nuclear forms of the Ah receptor in hepatoma cell line 1c1c7. Biochem Biophys Res Commun. 1992;182:55-62.
14. Chen HS, Perdew GH. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem. 1994;269:27554-27558. (Pubitemid 24346586)
15. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH. Hepatitis B virus X-associated protein 2 isa subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol. 1998;18:978-988. (Pubitemid 28063432)
16. Dong L, Ma Q, Whitlock JP Jr. DNA binding by the heterodimeric Ah receptor. Relationship to dioxin-induced CYP1A1 transcription in vivo. J Biol Chem. 1996;271:7942-7948.
17. Fujii-Kuriyama Y, Mimura J. Molecular mechanisms of AhR function in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun. 2005;338:311-317.
18. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 1999;13:20-25. (Pubitemid 29045112)
19. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. Cell. The nuclear receptor superfamily: the second decade. 1995;83:835-839. (Pubitemid 126663112)
20. Mably TA, Moore RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-/>-dioxin. 1. Effects on androgenic status. Toxicol Appl Pharmacol. 1992; 114:97-107.
21. Gray LE Jr, Kelce WR, Monosson E, Ostby JS, Birnbaum LS. Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol. 1995;131:108-118.
22. Theobald HM, Roman BL, Lin TM, Ohtani S, Chen SW, Peterson RE. 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits luminal cell differentiation and androgen responsiveness of the ventral prostate without inhibiting prostatic 5alpha-dihydro- testosterone formation or testicular androgen production in rat offspring. Toxicol Sci. 2000;58:324-338. (Pubitemid 32042431)
23. Roman BL, Sommer RJ, Shinomiya K, Peterson RE. In utero and lactational exposure of the male rat to 2,3,7,8- tetrachlorodibenzo-p-dioxin: impaired prostate growth and development without inhibited androgen production. Toxicol Appl Pharmacol. 1995;134:241-250.
24. Jana NR, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H. Cross-talk between 2,3,7,8-tetrachlorodibenzo-/>-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. Biochem Biophys Res Commun. 1999;256:462-468. (Pubitemid 29301128)
25. Jana NR, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C, Sone H. Comparative effects of 2,3,7,8-tetrachlorodibenzo-/>-dioxin on MCF-7, RL95-2, and LNCaP cells: Role of target steroid hormones in cellular responsiveness to CYP1A1 induction. Mol Cell Biol Res Commun. 2000;4:174-180.
26. Kizu R, Okamura K, Toriba A, Kakishima H, Mizokami A, Burnstein KL, et al. A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Arch Toxicol. 2003;77:335-343. (Pubitemid 36819264)
27. Barnes-Ellerbe S, Knudsen KE, Puga A. 2,3,7,8-Tetrachlorodi- benzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation. Mol Pharmacol. 2004;66:502-511. (Pubitemid 39329248)
28. Kizu R, Ishii K, Kobayashi J, Hashimoto T, Koh E, Namiki M, et al. Antiandrogenic effect of crude extract of C-heavy oil. Mat Sci Eng C. 2000;12:97-102.
29. Ohtake F, Baba A, Takada I, Okada M, Iwasaki K, Miki H, et al. Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature. 2007;446:562-566. (Pubitemid 46514731)
30. Ohtake F, Baba A, Fujii-Kuriyama Y, Kato S. Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings. Biochem Biophys Res Commun. 2008;370:541-546.
31. Kollara A, Brown TJ. Functional interaction of nuclear receptor coactivator 4 with aryl hydrocarbon receptor. Biochem Biophys Res Commun. 2006;346:526-534. (Pubitemid 43902715)
32. Haag P, Bektic J, Bartsch G, Klocker H, Eder IE. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol. 2005;96:251-258. (Pubitemid 41080506)
33. Pollenz RS, Buggy C. Ligand-dependent and -independent degradation of the human aryl hydrocarbon receptor (hAHR) in cell culture models. Chem Biol Interact. 2006;164:49-59.
34. Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, et al. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1 /c-Jun in the human prostate cancer cell line LNCaP. J Biol Chem. 1997;272:17485-17494. (Pubitemid 27311181)
35. Swanson HI, Chan WK, Bradfield CA. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Biol Chem. 1995;270:26292-26302.
36. Bacsi SG, Reisz-Porszasz S, Hankinson O. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence. Mol Pharmacol. 1995;47:432-438.